Drugs / BBC1501
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05803785 | Jul 2025 → Dec 2026 expected | age-related macular degeneration | Benobio Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BBC1501 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05803785 ↗ |
| Route | Intravitreal | “BBC1501 solution for Intravitreal injection” NCT05803785 ↗ |